Literature DB >> 25287326

Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.

Xiaorong Sun1, Yuhui Li, Min Dong, Wenwu Li, Ligang Xing.   

Abstract

Hepatoid adenocarcinoma of the stomach (HAS) is a rare distinct variant of gastric carcinoma with earlier metastases and worse prognosis compared to the more common intestinal types. It is often misdiagnosed as hepatocellular carcinoma, especially when primary HAS is insignificantly anatomically abnormal, produces high alpha-fetoprotein and develops early liver metastasis. In this case we show the significance of dual-time-point (18)F-fluorodeoxyglucose positron emission tomography (PET)/computed tomography (CT) in accurately diagnosing and staging HAS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25287326     DOI: 10.1007/s11604-014-0366-1

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  10 in total

1.  A hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma detected by F-18 FDG PET/CT imaging.

Authors:  Jian-hu Pan; Meng-jie Dong; Xiao-bo Ouyang
Journal:  Clin Nucl Med       Date:  2011-12       Impact factor: 7.794

2.  Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity.

Authors:  Yan Xiu; Chirdeep Bhutani; Thiruvenkatasamy Dhurairaj; Jian Q Yu; Simin Dadparvar; Swapna Reddy; Rakesh Kumar; Hua Yang; Abass Alavi; Hongming Zhuang
Journal:  Clin Nucl Med       Date:  2007-02       Impact factor: 7.794

3.  Hepatoid carcinoma of the pancreas combined with neuroendocrine carcinoma.

Authors:  Ji Ye Jung; Yoon Jae Kim; Hee Man Kim; Hong Jeoung Kim; Seung Woo Park; Si Young Song; Jae Bock Chung; Chang Moo Kang; Joo Yeon Pyo; Woo Ick Yang; Seungmin Bang
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

4.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.

Authors:  R Hustinx; R J Smith; F Benard; D I Rosenthal; M Machtay; L A Farber; A Alavi
Journal:  Eur J Nucl Med       Date:  1999-10

Review 5.  Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).

Authors:  C C Roberts; T V Colby; K P Batts
Journal:  Mayo Clin Proc       Date:  1997-12       Impact factor: 7.616

Review 6.  Hepatoid adenocarcinoma of the stomach.

Authors:  S Inagawa; J Shimazaki; M Hori; F Yoshimi; S Adachi; T Kawamoto; K Fukao; M Itabashi
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

7.  Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.

Authors:  E Nagai; T Ueyama; T Yao; M Tsuneyoshi
Journal:  Cancer       Date:  1993-09-15       Impact factor: 6.860

8.  alpha-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes.

Authors:  T Motoyama; K Aizawa; H Watanabe; M Fukase; K Saito
Journal:  Acta Pathol Jpn       Date:  1993-11

9.  Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer.

Authors:  Hojjat Ahmadzadehfar; Amir Sabet; Kristina Näke; Brigitte Hinterthaner; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Clin Nucl Med       Date:  2009-03       Impact factor: 7.794

10.  An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report.

Authors:  H Ishikura; Y Fukasawa; K Ogasawara; T Natori; Y Tsukada; M Aizawa
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

  10 in total
  3 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

2.  The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis.

Authors:  Kai Zhou; Anqiang Wang; Sheng Ao; Jiahui Chen; Ke Ji; Qifei He; Xin Ji; Xiaojiang Wu; Ji Zhang; Zhongwu Li; Zhaode Bu; Jiafu Ji
Journal:  BMC Cancer       Date:  2020-07-17       Impact factor: 4.430

Review 3.  Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuwen Zhou; Yuqing Wang; Jiaming Yuan; Xuelei Ma
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.